Cytel’s Advances in RWD Include Comparative Effectiveness and Efficacy Assessments Using Target Trial Emulation Solution

Real world data (RWD) is attractive to many stakeholders as it offers a time- and cost-saving method to complement or sometimes bypass randomized controlled trials. A new blog discusses how advances in RWD are leading to more insights than ever before, including in comparative effectiveness and efficacy assessments. Cytel’s Target Trial Emulation tool allows researchers to understand how a therapy works in a clinical setting and can support regulatory applications.

“The biases that used to plague the use of observational data can now be avoided. Specifically, we can eliminate immortal time bias which occurs when during the period of observation, there is some interval during which the outcome event cannot occur.” Read more here.

(Source: Mansha Sachdev, Cytel, 8/5/21)